Victory Capital Management Inc. increased its stake in Innospec Inc. (NASDAQ:IOSP – Free Report) by 1.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 922,220 shares of the specialty chemicals company’s stock after purchasing an additional 14,188 shares during the quarter. Victory Capital Management Inc.’s holdings in Innospec were worth $101,500,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the stock. Keybank National Association OH increased its stake in Innospec by 6.4% in the 4th quarter. Keybank National Association OH now owns 5,429 shares of the specialty chemicals company’s stock worth $598,000 after purchasing an additional 326 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Innospec by 4.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 352,577 shares of the specialty chemicals company’s stock worth $38,805,000 after purchasing an additional 16,055 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in Innospec by 91.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,802 shares of the specialty chemicals company’s stock worth $198,000 after purchasing an additional 863 shares in the last quarter. SVB Wealth LLC purchased a new position in Innospec in the 4th quarter worth about $238,000. Finally, Proficio Capital Partners LLC purchased a new position in Innospec in the 4th quarter worth about $1,623,000. Hedge funds and other institutional investors own 96.64% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com raised Innospec from a “hold” rating to a “buy” rating in a research note on Thursday.
Innospec Trading Up 0.4 %
Shares of IOSP opened at $98.16 on Thursday. Innospec Inc. has a 1-year low of $97.13 and a 1-year high of $133.71. The stock has a market capitalization of $2.45 billion, a P/E ratio of 69.13 and a beta of 1.09. The business’s 50-day moving average price is $109.59 and its 200 day moving average price is $112.17.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.05. Innospec had a return on equity of 12.27% and a net margin of 1.93%. The firm had revenue of $466.80 million during the quarter, compared to analyst estimates of $447.43 million. On average, research analysts predict that Innospec Inc. will post 6.18 earnings per share for the current year.
Insiders Place Their Bets
In other Innospec news, VP Philip John Boon sold 3,754 shares of the firm’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $103.30, for a total transaction of $387,788.20. Following the completion of the sale, the vice president now directly owns 20,079 shares in the company, valued at approximately $2,074,160.70. This trade represents a 15.75 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Corbin Barnes sold 598 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $103.06, for a total value of $61,629.88. Following the sale, the senior vice president now owns 8,051 shares of the company’s stock, valued at $829,736.06. The trade was a 6.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,696 shares of company stock worth $794,853. 1.52% of the stock is currently owned by company insiders.
Innospec Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Further Reading
- Five stocks we like better than Innospec
- Overbought Stocks Explained: Should You Trade Them?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to Evaluate a Stock Before Buying
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.